Topical Pimecrolimus 1% Cream for Resistant Seborrheic Dermatitis of the Face An Open-Label Study


Ozden M. G. , Tekin N. S. , Ilter N., Ankarali H.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, cilt.11, ss.51-54, 2010 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 11 Konu: 1
  • Basım Tarihi: 2010
  • Doi Numarası: 10.2165/11311160-000000000-00000
  • Dergi Adı: AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
  • Sayfa Sayıları: ss.51-54

Özet

Background: Treatment options for seborrheic dermatitis are numerous, including both topical and systemic agents (e.g. topical corticosteroids, oral antifungals, and psoralen plus UVA). However, long-term use of topical corticosteroids may lead to adverse effects. Pimecrolimus 1% cream is an effective and well tolerated treatment for seborrheic dermatitis.